Controversial Hydroxycut Legal Actions Have Recently Been Filed
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products stemming from a number of reports that people using the products were developing significant liver problems and other health concerns. Less than a week later, on May 4, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawyer alleges company negligence in informing the public about potential risks of the products. Naturally, it’s too shortly to know how the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action lawsuit is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less expensive, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there’s a settlement. At that point, the attorney who handled the suit will take his costs from the compensation that was awarded and then assign the leftover funds to the litigants in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the explanations that class action legal actions became so popular.
The initial class action lawsuit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall occurred in the United States where 23 cases of liver disorders and other health problems had been reported. Health Canada failed to receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained breathing, neurological, cardio, and gut issues as a consequence of Canadians using the products.
The Hydroxycut Lawsuit alleges that the company sold the products without properly informing the health risks that they could exposing consumers to. The complaint states that the company failed to publish the information on the product labels stating that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological problems. The suit goes on to allege that this was a blatant omission on the part of the company which purposely misled buyers concerning the security of the products.